Answer
Yes. It increases the risk of venous blood clots and must not be used by someone with an active or previous venous thromboembolic event.
Sources for this answer
- Raloxifene hydrochloride 60mg film-coated tabletsemc · SmPC Current selected SmPC · Version 1
- NHSNHS · NHS medicine guidance